The Sjogren’s syndrome is chronic autoimmune disease, in which the moisture-producing gland of the body is affected. It may be caused due to genetics, environmental changes or due to exposure to viruses or bacteria, which may result in primary or secondary Sjogren’s syndrome. The symptoms of this disease include Xerostomia (dry mouth), keratoconjunctivitis sicca (dry eye), skin dryness may result in lymphocytic infiltration and affects organs such as lungs, kidney, blood vessel and brain. According to American Sjogren’s syndrome association, about 70 % of patients results in positive anti-nuclear antibody test whereas 60-70% patients have positive rheumatoid (RF). The Sjogren’s syndrome majorly affects between the age of 40s and females are largely affected with Sjogren’s syndrome in comparison to males. The Sjogren’s syndrome treatment and diagnosis market growth is driven by the development of advanced techniques. Various tests aid in the diagnosis of Sjogren’s syndrome. The adoption towards newer diagnostic techniques encourages higher diagnosis of disease. However, lack of awareness of Sjogren’s syndrome among people is one of the factors inhibiting the growth of sjogren’s syndrome market. The improvised awareness among people enables in providing a platform for the opportunity to enhance in future Sjogren’s syndrome market.
Get Free Sample Copy @ https://www.omrglobal.com/request-sample/sjogrens-syndrome-market
The global Sjogren’s syndrome market is analyzed on the basis of geographical regions which are contributing significantly towards the growth of the market. North America and Europe hold strong share in global Sjogren syndrome market. Due to growing Sjogren’s syndrome and adoption of various techniques enables in driving the market. The Asia Pacific region is forecasted to exhibit rapid growth of Sjogren’s syndrome market due to rising awareness among people relating to Sjogren’s syndrome.
Browse for Full Report Description@ https://www.omrglobal.com/industry-reports/sjogrens-syndrome-market
The companies contributing in global market includes Allergen Inc., Amgen, Auven Therapeutics, Pfizer, Novartis, and Santen Pharmaceutical Co. Ltd. The companies are focusing to provide products and technologies for providing a diagnosis of Sjogren’s syndrome, which is fueling the global market. The companies provide competitive landscape by competing, the factors include price, quality, innovation, reputation, and distribution. The companies enter in strategic collaboration and partnership for boosting up the standard of the market.
The Sjogren’s syndrome market is segmented on the basis of the test, syndrome type, application, drug type and end users. The market segment for Sjogren’s syndrome by test, syndrome type, application, drug type and end user include erythrocyte sedimentation rate, musculoskeletal, imaging, cortisone and others. The advancement of technology and awareness regarding health concerns increases the demand for Sjogren’s syndrome market globally.
MARKET SEGMENTATION
GLOBAL SJOGREN’S SYNDROME MARKET, BY TEST
ON BASIS OF BLOOD TEST
- ERYTHROCYTE SEDIMENTATION RATE (ESR)
- IMMUNOGLOBULINS (IGS)
- RHEUMATOID FACTOR (RF)
- ANTI-NUCLEAR ANTIBODY (ANA)
ON BASIS OF EYE TEST
- SCHIRMER’S TEAR TEST
- SLIT LAMP TEST
- ROSE BENGAL TEST
ON BASIS OF IMAGING TEST
- SIALOGRAM
- SALIVARY SCINTIGRAPHY
BIOPSY
BY SYNDROME TYPE
- PRIMARY SJOGREN SYNDROME
- SECONDARY SJOGREN SYNDROME
BY APPLICATION
- EYE CARE
- VAGINAL DRYNESS
- MUSCULOSKELETAL
- SYSTEMIC
- DENTAL CARE
(This release has been published on OMR Industry Journal. OMR Industry Journal is not responsible for any content included in this release.)
